Cargando…
Evolving role of seneca valley virus and its biomarker TEM8/ANTXR1 in cancer therapeutics
Oncolytic viruses have made a significant inroad in cancer drug development. Numerous clinical trials are currently investigating oncolytic viruses both as single agents or in combination with various immunomodulators. Oncolytic viruses (OV) are an integral pillar of immuno-oncology and hold potenti...
Autores principales: | Corbett, Virginia, Hallenbeck, Paul, Rychahou, Piotr, Chauhan, Aman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458967/ https://www.ncbi.nlm.nih.gov/pubmed/36090051 http://dx.doi.org/10.3389/fmolb.2022.930207 |
Ejemplares similares
-
ANTXR1 Is a Prognostic Biomarker and Correlates With Stromal and Immune Cell Infiltration in Gastric Cancer
por: Huang, Xiaodong, et al.
Publicado: (2020) -
TEM8 in Oncogenesis: Protein Biology, Pre-Clinical Agents, and Clinical Rationale
por: Kareff, Samuel A., et al.
Publicado: (2023) -
Seneca Valley Virus Exploits TEM8, a Collagen Receptor Implicated in Tumor Growth
por: Evans, David J., et al.
Publicado: (2018) -
TEM8/ANTXR1-specific CAR T cells mediate toxicity in vivo
por: Petrovic, Kristina, et al.
Publicado: (2019) -
Machine Learning Classification Model for Functional Binding Modes of TEM-1 β-Lactamase
por: Wang, Feng, et al.
Publicado: (2019)